Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell Medical is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients.
Ferric Pyrophosphate Citrate (FPC)
Our innovative therapeutic was developed to replace iron loss in patients with anemia in an entirely different way. Our unique and differentiated molecule, Ferric Pyrophosphate Citrate (FPC), provides a novel mechanism of action with a physiologic approach. FPC donates iron directly to circulating transferrin making it immediately bioavailable for critical body processes, which allows the body to use the iron in a physiologic manner.
March 27, 2023
Rockwell Medical to Showcase its Hemodialysis Concentrates Portfolio at DialysisTechConneXion40Read more
February 28, 2023
Rockwell Medical Named 'Great Place to Work'Read more
February 16, 2023
Rockwell Medical to Release Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30, 2023Read more
February 13, 2023
Rockwell Medical and Concerto Renal Services Establish New Three-Year, Multi-Million Dollar Product Purchase AgreementRead more
February 2, 2023
Rockwell Medical Signs Three-Year, Multi-Million Dollar Supply Agreement with Largest Non-Profit Dialysis Provider in the United StatesRead more
Have any questions?